» Articles » PMID: 18761713

Induction of Sulfiredoxin Expression and Reduction of Peroxiredoxin Hyperoxidation by the Neuroprotective Nrf2 Activator 3H-1,2-dithiole-3-thione

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2008 Sep 3
PMID 18761713
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Peroxiredoxins are an important family of cysteine-based antioxidant enzymes that exert a neuroprotective effect in several models of neurodegeneration. However, under oxidative stress they are vulnerable to inactivation through hyperoxidation of their active site cysteine residues. We show that in cortical neurons, the chemopreventive inducer 3H-1,2-dithiole-3-thione (D3T), that activates the transcription factor Nuclear factor erythroid 2-related factor (Nrf2), inhibits the formation of inactivated, hyperoxidized peroxiredoxins following oxidative trauma, and protects neurons against oxidative stress. In both neurons and glia, Nrf2 expression and treatment with chemopreventive Nrf2 activators, including D3T and sulforaphane, up-regulates sulfiredoxin, an enzyme responsible for reducing hyperoxidized peroxiredoxins. Induction of sulfiredoxin expression is mediated by Nrf2, acting via a cis-acting antioxidant response element (ARE) in its promoter. The ARE element in Srxn1 contains an embedded activator protein-1 (AP-1) site which directs induction of Srxn1 by synaptic activity. Thus, raising Nrf2 activity in neurons prevents peroxiredoxin hyperoxidation and induces a new member of the ARE-gene family, whose enzymatic function of reducing hyperoxidized peroxiredoxins may contribute to the neuroprotective effects of Nrf2 activators.

Citing Articles

SRXN1 is a novel protective factor against methylmercury-induced apoptosis in C17.2 mouse neural stem cells.

Yamashita N, Yokoyama Y, Kumagai A, Fukushima R, Yamagata R, Hwang G Toxicol Res. 2025; 41(2):167-173.

PMID: 40013080 PMC: 11850658. DOI: 10.1007/s43188-024-00277-6.


Role of NRF2 in Pathogenesis of Alzheimer's Disease.

Chu C, Uruno A, Katsuoka F, Yamamoto M Antioxidants (Basel). 2025; 13(12.

PMID: 39765857 PMC: 11727090. DOI: 10.3390/antiox13121529.


Exploring the multifaceted role of NRF2 in brain physiology and cancer: A comprehensive review.

Moubarak M, Pagano Zottola A, Larrieu C, Cuvellier S, Daubon T, Martin O Neurooncol Adv. 2024; 6(1):vdad160.

PMID: 38221979 PMC: 10785770. DOI: 10.1093/noajnl/vdad160.


Association of SRXN1 Receptor Gene Polymorphism with Susceptibility to Periodontitis.

Murthykumar K, Varghese S, Jayaseelan V Contemp Clin Dent. 2023; 13(4):363-368.

PMID: 36686993 PMC: 9855261. DOI: 10.4103/ccd.ccd_309_21.


Altered responsiveness of the antioxidant system in chronically stressed animals: modulation by chronic lurasidone treatment.

Spero V, Paladini M, Brivio P, Riva M, Calabrese F, Molteni R Psychopharmacology (Berl). 2022; 239(8):2547-2557.

PMID: 35459959 PMC: 9294027. DOI: 10.1007/s00213-022-06140-6.


References
1.
Nguyen T, Yang C, Pickett C . The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med. 2004; 37(4):433-41. DOI: 10.1016/j.freeradbiomed.2004.04.033. View

2.
Woo H, Jeong W, Chang T, Park K, Park S, Yang J . Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J Biol Chem. 2004; 280(5):3125-8. DOI: 10.1074/jbc.C400496200. View

3.
Kotkow K, Orkin S . Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer. Mol Cell Biol. 1995; 15(8):4640-7. PMC: 230705. DOI: 10.1128/MCB.15.8.4640. View

4.
Zhang D . Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev. 2006; 38(4):769-89. DOI: 10.1080/03602530600971974. View

5.
Nioi P, McMahon M, Itoh K, Yamamoto M, Hayes J . Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem J. 2003; 374(Pt 2):337-48. PMC: 1223621. DOI: 10.1042/BJ20030754. View